Orum Therapeutics, Inc. (475830.KQ) — Stock Score Summary

Orum Therapeutics, Inc. (475830.KQ) has a MoatMap StockRank of 13/100 based on Quality (32/100), Value (33/100), and Momentum (32/100) factor scores. The current signal is STRONG SELL.

Orum Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases.

Key Financial Metrics

Price$48.18
Market Cap$865M
Price/Book11.83
Return on Equity-22.4%
Return on Invested Capital-27.5%
Debt/Equity9.73
Gross Margin97.9%
Operating Margin-292397.9%
Free Cash Flow$-12K

Orum Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Orum Therapeutics, Inc.’s (475830.KQ) StockRank?
MoatMap’s StockRank for Orum Therapeutics, Inc. (475830.KQ) is 13/100, with a Strong Sell signal. It is a composite of Quality (32), Value (33), and Momentum (32) factor ranks across MoatMap’s 19,000+ stock universe.
Does Orum Therapeutics, Inc. have an economic moat?
Orum Therapeutics, Inc. (475830.KQ) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Orum Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Orum Therapeutics, Inc. (475830.KQ) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Orum Therapeutics, Inc. in?
Orum Therapeutics, Inc. (475830.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks475830.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock